collaborative community studies of swine origin infuenza virus H1N1 (360G-Wellcome-091011_Z_09_A)

£78,376

To provide timely information on The occurrence of ILI and of PCR confirmed influenza in different population subgroups. Clinical illness in symptomatic patients including range, duration and severity of symptoms and sensitivity and specificity of symptoms and fever. Access to care and treatment (experience of helplines, access to antivirals, treatment with antibiotics) Effectiveness of antivirals delivered through NHS Uptake and effectiveness of pandemic vaccine delivered through NHS Household secondary attack rates and serial interval. Population behaviour changes through the pandemic and during illness. To provide a representative control group for case control studies of severe disease. To provide a human DNA bank for future studies of genetic susceptibility. To provide a virus bank for studies of viral evolution as it transmits through households and different geographic areas.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 78376
Applicant Surname Hayward
Approval Committee Immunology and Infectious Disease Funding Committee
Award Date 2009-09-30T00:00:00+00:00
Financial Year 2008/09
Grant Programme: Title Project Grant
Internal ID 091011/Z/09/A
Lead Applicant Prof Andrew Hayward
Partnership Name Swine Flu
Partnership Value 78376
Planned Dates: End Date 2010-09-30T00:00:00+00:00
Planned Dates: Start Date 2009-10-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London